These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 24641309)
1. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Wilhelm I; Krizbai IA Mol Pharm; 2014 Jul; 11(7):1949-63. PubMed ID: 24641309 [TBL] [Abstract][Full Text] [Related]
2. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709 [TBL] [Abstract][Full Text] [Related]
3. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes. Shawahna R; Decleves X; Scherrmann JM Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812 [TBL] [Abstract][Full Text] [Related]
4. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. Thomsen LB; Burkhart A; Moos T PLoS One; 2015; 10(8):e0134765. PubMed ID: 26241648 [TBL] [Abstract][Full Text] [Related]
5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869 [TBL] [Abstract][Full Text] [Related]
6. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068 [TBL] [Abstract][Full Text] [Related]
7. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies. Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814 [TBL] [Abstract][Full Text] [Related]
8. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis. Yusof SR; Avdeef A; Abbott NJ Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510 [TBL] [Abstract][Full Text] [Related]
9. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties. Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240 [TBL] [Abstract][Full Text] [Related]
10. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. Smith M; Omidi Y; Gumbleton M J Drug Target; 2007 May; 15(4):253-68. PubMed ID: 17487694 [TBL] [Abstract][Full Text] [Related]
11. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197 [TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. Bicker J; Alves G; Fortuna A; Falcão A Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194 [TBL] [Abstract][Full Text] [Related]
13. Murine in vitro model of the blood-brain barrier for evaluating drug transport. Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386 [TBL] [Abstract][Full Text] [Related]
14. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration. Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. Josserand V; Pélerin H; de Bruin B; Jego B; Kuhnast B; Hinnen F; Ducongé F; Boisgard R; Beuvon F; Chassoux F; Daumas-Duport C; Ezan E; Dollé F; Mabondzo A; Tavitian B J Pharmacol Exp Ther; 2006 Jan; 316(1):79-86. PubMed ID: 16210395 [TBL] [Abstract][Full Text] [Related]
16. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Bergmann S; Lawler SE; Qu Y; Fadzen CM; Wolfe JM; Regan MS; Pentelute BL; Agar NYR; Cho CF Nat Protoc; 2018 Dec; 13(12):2827-2843. PubMed ID: 30382243 [TBL] [Abstract][Full Text] [Related]
17. Methods to assess drug permeability across the blood-brain barrier. Nicolazzo JA; Charman SA; Charman WN J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894 [TBL] [Abstract][Full Text] [Related]
18. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease. Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978 [TBL] [Abstract][Full Text] [Related]
19. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793 [TBL] [Abstract][Full Text] [Related]
20. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Avdeef A Eur J Pharm Sci; 2011 Jun; 43(3):109-24. PubMed ID: 21514381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]